AstraZeneca PLC (LSE:AZN) - Overview

Stock Report

AstraZeneca PLC AZN

Last Price
GBX4,149.50

Day Change
-96.50|-2.27%

As of 30/11/2016
17:10:43 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,246.00p
Day Range4,144.00 - 4,291.12
Mkt Cap53.69Bil
52-Wk Range3,680.00 - 5,505.00
Yield %4.40
ISINGB0009895292
Volume4,746,978
P/E26.83
P/S3.24
P/CF23.25

Share Price

Total Returns 30/11/2016

 Chg (%)  
More ...
AstraZeneca PLC-9.56 
FTSE 100 TR GBP-2.77
 
Financials
201320142015
More ...
Income Statement
Turnover16,503.7116,124.3816,172.13
Operating Profit2,373.941,297.992,692.74
Net Profit1,644.23750.131,849.70
Reported EPS130.4659.52145.96
Balance Sheet
Current Assets12,277.6610,708.2910,860.27
Non Current Assets21,472.4826,870.4429,932.06
Total Assets33,750.1437,578.7340,792.33
Current Liabilities9,691.1111,114.2510,088.17
Total Liabilities19,710.6824,979.1628,234.53
Total Equity14,039.4612,599.5712,557.80
Cash Flow
Operating Cash Flow5,576.065,340.173,386.54
Net Change in Cash936.27-1,627.20-24.22
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20163,431.77334.30116.1612.700.11228.755.39
20173,231.03298.58-10.6814.22-1.33234.925.53

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
27/10/2016PurchaseMr. Graham Chipchase4,807.951004,808.00
01/08/2016PurchaseMr. Marc Dunoyer5,048.0043,7302,207,490.00
13/06/2016SaleMr. Pascal Soriot3,852.0084,3163,247,852.00
13/06/2016Transfer inMr. Pascal Soriot0.0084,3160.00

Company Profile

AstraZeneca PLC is a biopharmaceutical company. It is engaged in the discovery and development of new products, which are then manufactured, marketed and sold.
 

Sector

Drug Manufacturers - Major

Market Position

6 of 1867 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(10/11/2016) "Core EPS declined by 10.0%, reflecting the phasing of Other Operating Income towards the final quarter of the year"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)14.0713.5516.47
Div Yld (E)5.524.054.35
PEG (E)-2.660.180.84
ROCE83.38205.85-29.57
Op Mrgn14.57-16.08-35.29
EPS Grwth-5.3010.1324.73
Dividends
PreviousLatest
More ...
Record Date19/02/1612/08/16
Ex-Div18/02/1611/08/16
Paid21/03/1612/09/16
Amnt131.0068.70

Broker Sentiment

Strong Buy0
Buy3
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Leif Johansson
Chief Executive OfficerMr. Pascal Soriot
Chief Financial OfficerMr. Marc Dunoyer
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.